An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and Pyridoxine

Pyridoxine dependent-developmental and epileptic encephalopathy (PD-DEE) or pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder caused by biallelic pathogenic variants in ALDH7A1. It classically presents as intractable infantile-onset seizures unresponsive to multiple antiepil...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiyoung Kim, Angela Pipitone Dempsey, Sun Young Kim, Meral Gunay-Aygun, Hilary J. Vernon
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Genetics
Online Access:http://dx.doi.org/10.1155/2022/7138435
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562227099467776
author Jiyoung Kim
Angela Pipitone Dempsey
Sun Young Kim
Meral Gunay-Aygun
Hilary J. Vernon
author_facet Jiyoung Kim
Angela Pipitone Dempsey
Sun Young Kim
Meral Gunay-Aygun
Hilary J. Vernon
author_sort Jiyoung Kim
collection DOAJ
description Pyridoxine dependent-developmental and epileptic encephalopathy (PD-DEE) or pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder caused by biallelic pathogenic variants in ALDH7A1. It classically presents as intractable infantile-onset seizures unresponsive to multiple antiepileptic drugs (AEDs) but with a profound response to large doses of pyridoxine (B6). We report a case of PDE with an atypical clinical presentation. The patient presented at 3 days of life with multifocal seizures, fever, increased work of breathing, decreased left ventricular systolic function, and lactic acidosis, raising suspicion for a mitochondrial disorder or infectious process. Within 1.5 weeks of presentation, seizure activity resolved with antiepileptic therapy. Whole exome sequencing (WES) revealed homozygous pathogenic variants in ALDH7A1 (c.1279G > C, p.E427Q) and confirmed the diagnosis of PDE. Follow-up biochemical testing demonstrated elevated urine pipecolic acid. In the second week of life, the patient was initiated on triple therapy, including pyridoxine supplementation, low lysine diet, and arginine supplementation, which he tolerated well. Urine pipecolic acid levels responded accordingly after initiation of therapy. Our case illustrates the diagnostic challenges in PDE, the utility of rapid WES in such cases, and the response in urine pipecolic acid to therapy.
format Article
id doaj-art-e22b27bcb5e54b8ca3baa338dd53fcb9
institution Kabale University
issn 2090-6552
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Case Reports in Genetics
spelling doaj-art-e22b27bcb5e54b8ca3baa338dd53fcb92025-02-03T01:23:11ZengWileyCase Reports in Genetics2090-65522022-01-01202210.1155/2022/7138435An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and PyridoxineJiyoung Kim0Angela Pipitone Dempsey1Sun Young Kim2Meral Gunay-Aygun3Hilary J. Vernon4McKusick-Nathans Department of Genetic MedicineMcKusick-Nathans Department of Genetic MedicineMcKusick-Nathans Department of Genetic MedicineMcKusick-Nathans Department of Genetic MedicineMcKusick-Nathans Department of Genetic MedicinePyridoxine dependent-developmental and epileptic encephalopathy (PD-DEE) or pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder caused by biallelic pathogenic variants in ALDH7A1. It classically presents as intractable infantile-onset seizures unresponsive to multiple antiepileptic drugs (AEDs) but with a profound response to large doses of pyridoxine (B6). We report a case of PDE with an atypical clinical presentation. The patient presented at 3 days of life with multifocal seizures, fever, increased work of breathing, decreased left ventricular systolic function, and lactic acidosis, raising suspicion for a mitochondrial disorder or infectious process. Within 1.5 weeks of presentation, seizure activity resolved with antiepileptic therapy. Whole exome sequencing (WES) revealed homozygous pathogenic variants in ALDH7A1 (c.1279G > C, p.E427Q) and confirmed the diagnosis of PDE. Follow-up biochemical testing demonstrated elevated urine pipecolic acid. In the second week of life, the patient was initiated on triple therapy, including pyridoxine supplementation, low lysine diet, and arginine supplementation, which he tolerated well. Urine pipecolic acid levels responded accordingly after initiation of therapy. Our case illustrates the diagnostic challenges in PDE, the utility of rapid WES in such cases, and the response in urine pipecolic acid to therapy.http://dx.doi.org/10.1155/2022/7138435
spellingShingle Jiyoung Kim
Angela Pipitone Dempsey
Sun Young Kim
Meral Gunay-Aygun
Hilary J. Vernon
An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and Pyridoxine
Case Reports in Genetics
title An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and Pyridoxine
title_full An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and Pyridoxine
title_fullStr An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and Pyridoxine
title_full_unstemmed An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and Pyridoxine
title_short An Atypical Presentation of Pyridoxine-Dependent Epilepsy Diagnosed with Whole Exome Sequencing and Treated with Lysine Restriction and Supplementation with Arginine and Pyridoxine
title_sort atypical presentation of pyridoxine dependent epilepsy diagnosed with whole exome sequencing and treated with lysine restriction and supplementation with arginine and pyridoxine
url http://dx.doi.org/10.1155/2022/7138435
work_keys_str_mv AT jiyoungkim anatypicalpresentationofpyridoxinedependentepilepsydiagnosedwithwholeexomesequencingandtreatedwithlysinerestrictionandsupplementationwitharginineandpyridoxine
AT angelapipitonedempsey anatypicalpresentationofpyridoxinedependentepilepsydiagnosedwithwholeexomesequencingandtreatedwithlysinerestrictionandsupplementationwitharginineandpyridoxine
AT sunyoungkim anatypicalpresentationofpyridoxinedependentepilepsydiagnosedwithwholeexomesequencingandtreatedwithlysinerestrictionandsupplementationwitharginineandpyridoxine
AT meralgunayaygun anatypicalpresentationofpyridoxinedependentepilepsydiagnosedwithwholeexomesequencingandtreatedwithlysinerestrictionandsupplementationwitharginineandpyridoxine
AT hilaryjvernon anatypicalpresentationofpyridoxinedependentepilepsydiagnosedwithwholeexomesequencingandtreatedwithlysinerestrictionandsupplementationwitharginineandpyridoxine
AT jiyoungkim atypicalpresentationofpyridoxinedependentepilepsydiagnosedwithwholeexomesequencingandtreatedwithlysinerestrictionandsupplementationwitharginineandpyridoxine
AT angelapipitonedempsey atypicalpresentationofpyridoxinedependentepilepsydiagnosedwithwholeexomesequencingandtreatedwithlysinerestrictionandsupplementationwitharginineandpyridoxine
AT sunyoungkim atypicalpresentationofpyridoxinedependentepilepsydiagnosedwithwholeexomesequencingandtreatedwithlysinerestrictionandsupplementationwitharginineandpyridoxine
AT meralgunayaygun atypicalpresentationofpyridoxinedependentepilepsydiagnosedwithwholeexomesequencingandtreatedwithlysinerestrictionandsupplementationwitharginineandpyridoxine
AT hilaryjvernon atypicalpresentationofpyridoxinedependentepilepsydiagnosedwithwholeexomesequencingandtreatedwithlysinerestrictionandsupplementationwitharginineandpyridoxine